These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Rerknimitr R; Fogel EL; Kalayci C; Esber E; Lehman GA; Sherman S Gastrointest Endosc; 2002 Dec; 56(6):885-9. PubMed ID: 12447303 [TBL] [Abstract][Full Text] [Related]
30. Alterations of the bile microbiome in primary sclerosing cholangitis. Liwinski T; Zenouzi R; John C; Ehlken H; Rühlemann MC; Bang C; Groth S; Lieb W; Kantowski M; Andersen N; Schachschal G; Karlsen TH; Hov JR; Rösch T; Lohse AW; Heeren J; Franke A; Schramm C Gut; 2020 Apr; 69(4):665-672. PubMed ID: 31243055 [TBL] [Abstract][Full Text] [Related]
31. Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods. Lombard M; Farrant M; Karani J; Westaby D; Williams R Gut; 1991 Nov; 32(11):1364-8. PubMed ID: 1752470 [TBL] [Abstract][Full Text] [Related]
32. Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. Kaya M; Beştaş R; Bacalan F; Bacaksız F; Arslan EG; Kaplan MA World J Gastroenterol; 2012 Jul; 18(27):3585-9. PubMed ID: 22826624 [TBL] [Abstract][Full Text] [Related]
33. Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Wagner S; Gebel M; Meier P; Trautwein C; Bleck J; Nashan B; Manns MP Endoscopy; 1996 Sep; 28(7):546-51. PubMed ID: 8911801 [TBL] [Abstract][Full Text] [Related]
34. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma. Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633 [TBL] [Abstract][Full Text] [Related]
35. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival. Rudolph G; Gotthardt D; Kloeters-Plachky P; Rost D; Kulaksiz H; Stiehl A J Hepatol; 2010 Aug; 53(2):313-7. PubMed ID: 20472317 [TBL] [Abstract][Full Text] [Related]
36. Deterioration of cholestasis after endoscopic retrograde cholangiography in advanced primary sclerosing cholangitis. Beuers U; Spengler U; Sackmann M; Paumgartner G; Sauerbruch T J Hepatol; 1992 May; 15(1-2):140-3. PubMed ID: 1506631 [TBL] [Abstract][Full Text] [Related]
37. Primary sclerosing cholangitis in Turkish patients: characteristic features and prognosis. Ataseven H; Parlak E; Yüksel I; Başar O; Ertuğrul I; Saşmaz N; Sahin B Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):312-5. PubMed ID: 19502174 [TBL] [Abstract][Full Text] [Related]
38. [A clinical and pathological analysis of 22 cases of primary sclerosing cholangitis]. Liu HH; Fu JL; Luo SQ; Sun YL; Dong JH; Guo TS; Wang FS Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):125-8. PubMed ID: 23663885 [TBL] [Abstract][Full Text] [Related]
39. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. Stiehl A; Rudolph G; Klöters-Plachky P; Sauer P; Walker S J Hepatol; 2002 Feb; 36(2):151-6. PubMed ID: 11830325 [TBL] [Abstract][Full Text] [Related]